Trial Profile
A Pharmacogenetic Trial of Tacrolimus Dosing After Pediatric Transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics
- 18 Aug 2016 Status changed from discontinued to completed.
- 25 Feb 2016 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 30 Sep 2015 Planned number of patients changed from 60 to 95 as reported by ClinicalTrials.gov record.